Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-15
DOI
10.1038/s41598-017-18446-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
- (2017) Fabao Liu et al. NATURE CELL BIOLOGY
- miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1
- (2017) Li Zheng et al. OncoTargets and Therapy
- Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition
- (2017) Evgenia Shishkova et al. Nature Communications
- CARM1 Preferentially Methylates H3R17 over H3R26 through a Random Kinetic Mechanism
- (2016) Suzanne L. Jacques et al. BIOCHEMISTRY
- Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening
- (2016) Renato Ferreira de Freitas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6
- (2016) Yudao Shen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
- (2015) Elayne Chan-Penebre et al. Nature Chemical Biology
- Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound
- (2015) Lorna H. Mitchell et al. ACS Medicinal Chemistry Letters
- CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis
- (2014) Lu Wang et al. CANCER CELL
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Loss of CARM1 is linked to reduced HuR function in replicative senescence
- (2013) Lijun Pang et al. BMC MOLECULAR BIOLOGY
- Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes
- (2013) Hongxia Cheng et al. Diagnostic Pathology
- Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis
- (2013) SHIGEHIRO OSADA et al. ONCOLOGY REPORTS
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PRMT4 Blocks Myeloid Differentiation by Assembling a Methyl-RUNX1-Dependent Repressor Complex
- (2013) Ly P. Vu et al. Cell Reports
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
- (2011) John S. Sack et al. BIOCHEMICAL JOURNAL
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular Activity
- (2011) Donghang Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Coactivator Role of CARM1 in the Dysregulation of -Catenin Activity in Colorectal Cancer Cell Growth and Gene Expression
- (2011) C.-Y. Ou et al. MOLECULAR CANCER RESEARCH
- Non-Competitive Inhibition by Active Site Binders
- (2010) Yuval Blat Chemical Biology & Drug Design
- 1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)
- (2009) Eric Therrien et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)
- (2009) Tram Huynh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)—Hit to Lead studies
- (2009) Honghe Wan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans
- (2009) S. S. Wolf CELLULAR AND MOLECULAR LIFE SCIENCES
- Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)
- (2008) Ashok V. Purandare et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1)
- (2008) Martin Allan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-regulation of E2F1
- (2008) S. Frietze et al. CANCER RESEARCH
- CARM1 promotes adipocyte differentiation by coactivating PPARγ
- (2008) Neelu Yadav et al. EMBO REPORTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now